Celularity Inc. CELU
0.73 USD -0.08 (-10.32%)
At closeNov 5, 2026, 7:47 PM EST
0.71 -0.02 -2.11%
After hours · Nov 5, 7:47 PM ET
0.721 Day range 0.82
0.598 52-week range 2.10
- YTD
- -34.66%
- 1 year
- -60.58%
Financial health
Altman Z-Score
-16.25 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.3×
FY 2018 5y median -0.3× FY 2025
P/S 1.1×
FY 2018 5y median 1.9× FY 2025
P/B -0.7×
FY 2018 5y median 1.1× FY 2025
P/FCF -2.1×
FY 2018 5y median -2.1× FY 2025
EV/EBITDA -0.8×
FY 2018 5y median -1.7× FY 2025
EV/Sales 2.4×
FY 2018 5y median 4.8× FY 2025
FCF Yield -46.6%
FY 2018 5y median -46.6% FY 2025
Profitability
Gross Margin 24.4%
FY 2018 5y median 29.7% FY 2025
Operating Margin -230.9%
FY 2018 5y median -230.9% FY 2025
Net Margin -345.4%
FY 2018 5y median -345.4% FY 2025
ROE 241.0%
FY 2018 5y median -100.7% FY 2025
ROIC -151.1%
FY 2018 5y median -44.9% FY 2025
ROA -85.5%
FY 2018 5y median -43.6% FY 2025
Growth (YoY)
Revenue -51.0%
FY 2018 FY 2025
Operating Income -59.8%
FY 2018 FY 2025
EPS (diluted) -35.7%
FY 2018 FY 2025
Free Cash Flow -102.0%
FY 2018 FY 2025
Financial Health
Current Ratio 0.2×
FY 2018 5y median 0.4× FY 2025
Quick Ratio 0.1×
FY 2018 5y median 0.3× FY 2025
Debt / Equity -1.1×
FY 2018 5y median 0.3× FY 2025
Net Debt / EBITDA -0.4×
FY 2018 5y median -0.4× FY 2025
Interest Coverage -9.1×
FY 2018 5y median -9.1× FY 2025
Dividends
Dividend Yield 20.8%
FY 2018 5y median 0.0% FY 2025
Payout Ratio -6.4%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
